Cargando…
Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate
Autores principales: | Hartono, Stella P., Sharma, Hemant P., Bundy, Vanessa, Thompkins, Jessica D., Kochis, Suzanne R., Brooks, Joel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277098/ https://www.ncbi.nlm.nih.gov/pubmed/35842413 http://dx.doi.org/10.1016/j.jaip.2022.05.035 |
Ejemplares similares
-
Endotyping of IgE-mediated polyethylene glycol and/or polysorbate 80 allergy.
por: Ieven, Toon, et al.
Publicado: (2023) -
COVID-19 Vaccination in Patients with Documented Reactions to Polyethylene Glycol or Polysorbate
por: Tang, Monica, et al.
Publicado: (2022) -
Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report
por: Pitlick, Mitchell M., et al.
Publicado: (2021) -
Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics
por: Otani, Iris M., et al.
Publicado: (2022) -
Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work‐up and decision points for vaccination during the COVID‐19 pandemic
por: Mortz, Charlotte G., et al.
Publicado: (2022)